×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: rsv | vaccine | manufacturers | white house | biden | sanofi | astrazeneca

White House Asks RSV Vaccine Makers to Meet Demand

positive RSV test
(Dreamstime)

Tuesday, 28 November 2023 02:52 PM EST

Senior Biden administration officials met with RSV vaccine makers this week to underscore the need for manufacturers such as Sanofi and AstraZeneca to urgently meet demand as winter approaches, the White House said on Tuesday.

At a meeting at the White House on Monday, officials and manufacturers also agreed to plan now to meet next year's demand for the vaccines targeting respiratory syncytial virus, which generally causes mild, cold-like symptoms but can develop into severe illness in infants and older adults.

"Monday's meeting follows numerous in-person and virtual meetings to seek ways manufacturers can make more RSV immunizations available for infants," the White House said in a statement.

Representatives for Sanofi and AstraZeneca did not immediately respond to a request for comment.

Separately, the U.S. Centers for Disease Control and Prevention said it had expedited the release of more than 77,000 additional doses of Sanofi and AstraZeneca's RSV drug Beyfortus which was approved earlier this year to prevent the disease in infants and toddlers.

RSV cases in the U.S. began a sharp upward trend in the middle of October and were at the highest level since January last winter with 4,952 cases detected through testing in the week ended Nov. 4, according to the CDC website.

© 2024 Thomson/Reuters. All rights reserved.


Health-News
Senior Biden administration officials met with RSV vaccine makers this week to underscore the need for manufacturers such as Sanofi and AstraZeneca to urgently meet demand as winter approaches, the White House said on Tuesday. At a meeting at the White House on Monday,...
rsv, vaccine, manufacturers, white house, biden, sanofi, astrazeneca
206
2023-52-28
Tuesday, 28 November 2023 02:52 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved